The Autism Consortium study reveals that chromosomal microarray analysis (CMA) has the highest detection rate among clinically available genetic tests for autism spectrum disorders. CMA identified 18.2% of patients with deletions or duplications, compared to 2.23% and 0.46% for standard testing methods. The study recommends CMA as part...
The Autism Consortium's fourth annual symposium brought together researchers, clinicians, and families to discuss the latest findings on the causes of autism. The symposium highlighted promising areas of research, including the role of chromosome 16p11.2 in susceptibility for autism spectrum disorders.
The Autism Consortium has published a groundbreaking study defining the mechanism behind Rett syndrome, a neurodevelopmental disorder primarily affecting girls and a leading cause of autism. The research discovered that targeting the IGF1 signaling axis could be a promising therapeutic strategy for treating or reversing Rett Syndrome.
The Autism Consortium has released genetic data from 3,000 individuals with autism spectrum disorders to the scientific community. The data set provides a comprehensive look at genetic variation patterns in families with autism, shedding light on the complex causes of the disorder.